18 terminated. 18 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 18 | Terminated 18 |
| Phase 3 | 3 | Terminated 3 |
Follow Thromboembolism: new trials by email Literature Review of Thromboembolism trials Research Report on Thromboembolism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19 Rivaroxaban, Standard Of Care (SOC) - COVID-19 | Phase 2 | Terminated | Charite University, Berlin, Germany | 111 | 2020-11-30 | 2022-01-12 |
| Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs Apixaban 2.5 MG - Venous Thromboembolism | Phase 2 | Terminated | Instituto de Investigacion Sanitaria La Fe | 60 | 2019-04-12 | 2021-02-15 |
| WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism Dalteparin - Cancer, Venous Thromboembolism | Phase 2 | Terminated | Ottawa Hospital Research Institute | 92 | 2018-03-21 | 2024-01-23 |
| Apixaban For Thromboprophylaxis In Patients With Acute Spinal Cord Injury Apixaban, Low molecular weight heparin - Spinal Cord Injuries, Venous Thromboembolism | Phase 2 | Terminated | McMaster University | 8 | 2017-09-01 | 2020-02-20 |
| Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia Platelet Transfusion - Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | Terminated | Fred Hutchinson Cancer Center | 4 | 2017-06-09 | 2019-10-21 |
| Catheter-Related Early Thromboprophylaxis With Enoxaparin (CRETE) Trial Enoxaparin - Deep Venous Thrombosis | Phase 2 | Terminated | Yale University | 51 | 2017-04-05 | 2020-07-13 |
| STAT-STatin and Aspirin in Trauma Aspirin and Rosuvastatin, Placebo (for Aspirin and Rosuvastatin) - Wounds and Injuries, Venous Thromboembolism | Phase 2 | Terminated | Denver Health and Hospital Authority | 43 | 2017-02-03 | 2023-04-27 |
| Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome. Enoxaparin - Nephrotic Syndrome | Phase 2 / Phase 3 | Terminated | Military Institute od Medicine National Research Institute | 65 | 2015-10-01 | 2023-01-30 |
| Anticoagulation Length in Cancer Associated Thrombosis Low Molecular Weight Heparin (LMWH) - Cancer, Thrombosis | Phase 2 | Terminated | Cardiff University | 2 | 2013-12-01 | 2018-10-29 |
| Single Session Percutaneous Mechanical Thrombectomy for the Treatment of Ilio-femoral Deep Vein Thrombosis: A Preliminary Evaluation Thrombectomy - Deep Vein Thrombosis, Venous Thromboembolism | Phase 2 | Terminated | Ottawa Hospital Research Institute | 26 | 2013-11-01 | 2015-04-17 |
| Follow on Study From RE-ALIGN dabigatran etexilate low dose, warfarin 5mg, dabigatran etexilate intermediate dose - Thromboembolism, Heart Valve Prosthesis | Phase 2 | Terminated | Boehringer Ingelheim | 158 | 2011-12-01 | 2014-07-11 |
| Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis Endovascular thrombolysis, Heparin - Sinus Thrombosis, Intracranial | Phase 2 / Phase 3 | Terminated | Jan Stam, MD, PhD | 67 | 2011-09-01 | 2017-02-14 |
| Effect of ARC1779 on Cerebral Microembolism in Patients Undergoing Carotid Endarterectomy ARC1779 Injection, Placebo (normal saline) - Intracranial Embolism, Cerebral Thromboembolism | Phase 2 | Terminated | Archemix Corp. | 100 | 2009-02-01 | 2010-02-10 |
| Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma Aspirin, Placebo - Glioblastoma | Phase 2 | Terminated | M.D. Anderson Cancer Center | 1 | 2008-11-01 | 2011-12-08 |
| Statins to Reduce D-dimer Levels in Patients With Venous Thrombosis atorvastatin, diet - Venous Thromboembolism, Hypercholesterolemia | Phase 2 | Terminated | Università degli Studi dell'Insubria | 10 | 2007-05-01 | 2011-08-19 |
| Evaluation of the TriActiv ProGuard System During Carotid Artery Stenting Carotid Stent Implantation, Embolic Protection - Carotid Stenosis | Phase 2 / Phase 3 | Terminated | Kensey Nash Corporation | 400 | 2006-11-01 | 2007-07-25 |
| Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer Tinzaparin sodium - Venous Thromboembolism, Cancer | Phase 2 | Terminated | University of Southern California | 131 | 2005-07-01 | 2017-07-06 |
| Intra-arterial Microplasmin Administration in Patients With Acute Peripheral Arterial Occlusion Microplasmin - Arterial Occlusive Diseases | Phase 2 | Terminated | ThromboGenics | 19 | 2005-03-01 | 2014-04-07 |
Venous Thromboembolism (13) · Venous Thrombosis (4) · Neoplasms (3) · Carotid Stenosis (2) · Hematologic Diseases (2) · Intracranial Embolism (2) · Pulmonary Embolism (2) · Arterial Occlusive Diseases (1) · COVID-19 (1) · Critical Illness (1) · Glioblastoma (1) · Hemorrhage (1) · Hypercholesterolemia (1) · Intracranial Thrombosis (1)
Cardiovascular Diseases (18) · Embolism and Thrombosis (18) · Vascular Diseases (18) · Pathological Conditions, Signs and Symptoms (5) · Central Nervous System Diseases (4) · Nervous System Diseases (4) · Pathologic Processes (4) · Brain Diseases (3) · Cerebrovascular Disorders (3) · Hemic and Lymphatic Diseases (3) · Intracranial Embolism and Thrombosis (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Thrombosis (3)
Enoxaparin (4) · Dalteparin (3) · Aspirin (2) · Heparin, Low-Molecular-Weight (2) · Tinzaparin (2) · apixaban (2) · ARC 1779 (1) · Atorvastatin (1) · Dabigatran (1) · Diet (1) · Embolic Protection Devices (1) · Heparin (1) · Platelet Transfusion (1) · Rivaroxaban (1) · Rosuvastatin Calcium (1)
Ottawa Hospital Research Institute (2) · Archemix Corp. (1) · Boehringer Ingelheim (1) · Cardiff University (1) · Charite University, Berlin, Germany (1) · Denver Health and Hospital Authority (1) · Fred Hutchinson Cancer Center (1) · Instituto de Investigacion Sanitaria La Fe (1) · Jan Stam, MD, PhD (1) · Kensey Nash Corporation (1) · M.D. Anderson Cancer Center (1) · McMaster University (1) · Military Institute od Medicine National Research Institute (1) · ThromboGenics (1) · University of Southern California (1)
United States (7) · Canada (5) · Germany (3) · Belgium (2) · France (2) · Netherlands (2) · Poland (2) · United Kingdom (2) · China (1) · Czechia (1) · Denmark (1) · Italy (1) · Norway (1) · Portugal (1) · Spain (1)
Anna Matyjek, MD, PhD (1) · Charles BL Majoie, MD, PhD (1) · David Garcia (1) · Davide Imberti (1) · E Houdart, MD, PhD (1) · E. Vincent S Faustino, MD, MHS (1) · Ernest E Moore, MD (1) · Esteban Gandara, MD (1) · Gary S Roubin, MD (1) · Gualtiero Palareti (1)
PMID 21700934, PMID 22340437, PMID 23991661, PMID 26490434, PMID 30957581, PMID 32421159, PMID 33372745, PMID 33502773, PMID 33566465, PMID 34884411, PMID 35244208, PMID 41211763
P30CA015704 (1), R21HD089131 (1)